Dr. Mordecai Klein, MD

Cardiovascular Disease Plano, TX Male
NPI: 1881629541
Total Payments
$162,433
2024 Payments
$157,929
Companies
23
Transactions
186
Medicare Patients
4,858
Medicare Billing
$570,913

Payment Breakdown by Category

Research$157,914 (97.2%)
Food & Beverage$4,107 (2.5%)
Education$411.77 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $157,914 1 97.2%
Food and Beverage $4,107 182 2.5%
Education $411.77 3 0.3%

Payments by Type

Research
$157,914
1 transactions
General
$4,519
185 transactions

Top Paying Companies

Company Total Records Latest Year
Eli Lilly and Company $157,914 1 $0 (2024)
Abbott Laboratories $2,484 63 $0 (2024)
Novartis Pharmaceuticals Corporation $444.04 48 $0 (2018)
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $442.56 21 $0 (2023)
Boston Scientific Corporation $198.08 3 $0 (2023)
E.R. Squibb & Sons, L.L.C. $196.74 20 $0 (2017)
ABIOMED $146.20 1 $0 (2019)
Philips Electronics North America Corporation $94.81 2 $0 (2023)
Braemar Manufacturing, LLC $82.82 2 $0 (2018)
Edwards Lifesciences Corporation $75.71 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $157,929 2 Eli Lilly and Company ($157,914)
2023 $343.31 9 Abbott Laboratories ($215.66)
2022 $235.49 15 Abbott Laboratories ($164.18)
2021 $670.69 18 Abbott Laboratories ($610.65)
2020 $460.10 12 Abbott Laboratories ($343.82)
2019 $571.40 13 Abbott Laboratories ($299.73)
2018 $1,014 45 Abbott Laboratories ($601.35)
2017 $1,209 72 Novartis Pharmaceuticals Corporation ($320.18)

All Payment Transactions

186 individual payment records from CMS Open Payments — Page 1 of 8

Date Company Product Nature Form Amount Type
12/11/2024 Abbott Laboratories CONFIRM RX (Device) Food and Beverage In-kind items and services $14.87 General
Category: Cardiac Rhythm Management
07/23/2024 Eli Lilly and Company — — Cash or cash equivalent $157,914.00 Research
Study: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF LEPODISIRAN ON THE REDUCTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ADULTS WITH ELEVATED LIPOPROTEIN(A) WHO HAVE ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR ARE AT RISK FOR A FIRST CARDIOVASCULAR EVENT - ACCLAIM-LP(A)
11/30/2023 Abbott Laboratories XIENCE SKYPOINT (Device) Food and Beverage In-kind items and services $153.87 General
Category: Vascular
09/12/2023 PFIZER INC. VYNDAQEL (Drug) Food and Beverage In-kind items and services $20.21 General
Category: CARDIOVASCULAR
08/23/2023 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $17.71 General
Category: Electromedical and Electrotherapeutic Apparatus
08/22/2023 Boston Scientific Corporation BodyGuardian (Device) Food and Beverage In-kind items and services $31.57 General
Category: CDS - BG Mini_RM
06/07/2023 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $19.60 General
Category: CARDIOVASCULAR
05/30/2023 Abbott Laboratories CONFIRM RX (Device) Food and Beverage In-kind items and services $17.28 General
Category: Cardiac Rhythm Management
04/24/2023 Abbott Laboratories MERLIN@HOME (Device) Food and Beverage In-kind items and services $38.80 General
Category: Cardiac Rhythm Management
03/18/2023 Abbott Laboratories CONFIRM RX (Device) Food and Beverage In-kind items and services $5.71 General
Category: Cardiac Rhythm Management
03/16/2023 Philips Electronics North America Corporation (5054) Geneva (Device) Food and Beverage Cash or cash equivalent $38.56 General
Category: Medical Device
12/15/2022 Abbott Laboratories CONFIRM RX (Device) Food and Beverage In-kind items and services $7.20 General
Category: Cardiac Rhythm Management
12/15/2022 Abbott Laboratories CONFIRM RX (Device) Food and Beverage In-kind items and services $5.00 General
Category: Cardiac Rhythm Management
10/26/2022 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $12.79 General
Category: Cardiology
09/19/2022 Abbott Laboratories CONFIRM RX (Device) Food and Beverage In-kind items and services $8.34 General
Category: Cardiac Rhythm Management
09/13/2022 Abbott Laboratories CONFIRM RX (Device) Food and Beverage In-kind items and services $20.66 General
Category: Cardiac Rhythm Management
08/25/2022 Merck Sharp & Dohme LLC VERQUVO (Drug) Food and Beverage In-kind items and services $11.91 General
Category: CARDIOVASCULAR
08/01/2022 Itamar Medical Inc WatchPAT (Device) Food and Beverage Cash or cash equivalent $20.37 General
Category: Sleep Apnea testing
06/30/2022 Abbott Laboratories CONFIRM RX (Device) Food and Beverage In-kind items and services $14.68 General
Category: Cardiac Rhythm Management
06/14/2022 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $12.64 General
Category: Cardiovascular & Metabolism
05/04/2022 Abbott Laboratories CONFIRM RX (Device) Food and Beverage In-kind items and services $6.00 General
Category: Cardiac Rhythm Management
05/02/2022 Abbott Laboratories CONFIRM RX (Device) Food and Beverage In-kind items and services $41.56 General
Category: Cardiac Rhythm Management
04/11/2022 Abbott Laboratories CONFIRM RX (Device) Food and Beverage In-kind items and services $36.40 General
Category: Cardiac Rhythm Management
02/09/2022 Abbott Laboratories CONFIRM RX (Device) Food and Beverage In-kind items and services $13.42 General
Category: Cardiac Rhythm Management
02/07/2022 Medtronic, Inc. LINQ II (Device) Food and Beverage In-kind items and services $13.60 General
Category: Cardiac Diagnostics and Monitoring
123…8»

Research Studies & Clinical Trials

Study Name Company Amount Records
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF LEPODISIRAN ON THE REDUCTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ADULTS WITH ELEVATED LIPOPROTEIN(A) WHO HAVE ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR ARE AT RISK FOR A FIRST CARDIOVASCULAR EVENT - ACCLAIM-LP(A) Eli Lilly and Company $157,914 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 13 933 1,590 $306,847 $103,295
2022 14 1,378 2,398 $382,602 $168,718
2021 13 1,127 2,051 $312,590 $141,154
2020 16 1,420 2,622 $409,103 $157,746
Total Patients
4,858
Total Services
8,661
Medicare Billing
$570,913
Procedure Codes
57

All Medicare Procedures & Services

57 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 282 546 $138,046 $47,032 34.1%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Office 2023 98 103 $44,985 $14,168 31.5%
78452 Nuclear medicine studies of heart muscle at rest and with stress and spect Office 2023 39 42 $35,914 $14,146 39.4%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 295 592 $24,141 $5,754 23.8%
J2785 Injection, regadenoson, 0.1 mg Office 2023 25 104 $7,800 $5,040 64.6%
93880 Ultrasound of both sides of head and neck blood flow Office 2023 37 37 $15,421 $4,720 30.6%
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose Office 2023 40 40 $14,615 $4,390 30.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 22 22 $7,823 $2,285 29.2%
93015 Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician Office 2023 43 46 $8,850 $2,243 25.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 11 12 $3,161 $1,566 49.6%
93280 Programming of dual lead pacemaker system Office 2023 12 13 $2,210 $726.22 32.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 11 11 $1,908 $710.52 37.2%
93294 Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days Office 2023 18 22 $1,974 $513.26 26.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 293 551 $96,425 $50,616 52.5%
78452 Nuclear medicine studies of heart muscle at rest and with stress and spect Office 2022 79 80 $56,000 $27,515 49.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 160 218 $51,884 $25,671 49.5%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Office 2022 140 141 $51,465 $20,763 40.3%
J2785 Injection, regadenoson, 0.1 mg Office 2022 54 213 $15,975 $10,359 64.8%
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose Office 2022 81 83 $30,155 $9,077 30.1%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 325 799 $31,161 $7,609 24.4%
93880 Ultrasound of both sides of head and neck blood flow Office 2022 40 40 $14,120 $5,914 41.9%
93015 Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician Office 2022 81 83 $15,355 $4,126 26.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 36 36 $9,756 $3,783 38.8%
93294 Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days Office 2022 29 58 $4,118 $1,262 30.6%
93296 Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days Office 2022 35 69 $4,485 $1,158 25.8%
123»

About Dr. Mordecai Klein, MD

Dr. Mordecai Klein, MD is a Cardiovascular Disease healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881629541.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mordecai Klein, MD has received a total of $162,433 in payments from pharmaceutical and medical device companies, with $157,929 received in 2024. These payments were reported across 186 transactions from 23 companies. The most common payment nature is "" ($157,914).

As a Medicare-enrolled provider, Klein has provided services to 4,858 Medicare beneficiaries, totaling 8,661 services with total Medicare billing of $570,913. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.

Practice Information

  • Specialty Cardiovascular Disease
  • Location Plano, TX
  • Active Since 07/11/2006
  • Last Updated 05/05/2020
  • Taxonomy Code 207RC0000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1881629541

Products in Payments

  • Confirm Rx (Device) $1,058
  • ENTRESTO (Drug) $444.04
  • LifeVest (Device) $442.56
  • Merlin Connectivity and Remote (Device) $338.87
  • CONFIRM RX (Device) $202.04
  • ELIQUIS (Drug) $196.74
  • Connectivity and Remote care (Device) $171.54
  • Pacemakers (Device) $171.51
  • XIENCE SKYPOINT (Device) $153.87
  • Impella (Device) $146.20
  • WATCHMAN (Device) $131.08
  • Assurity Pacemaker (Device) $119.48
  • Quadra Allure MP RF CRT Pacemkr (Device) $91.46
  • Cardiac Monitoring Suite (Device) $82.82
  • Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $75.71
  • (7999) SRC Undivided (Device) $56.25
  • Accent Pacemaker (Device) $48.37
  • Mitra Clip system (Device) $45.79
  • ICDs (Device) $44.63
  • Repatha (Biological) $40.62

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Cardiovascular Disease Doctors in Plano

Srinivasa Potluri, Md, MD

Cardiovascular Disease — Payments: $783,265

Cardiovascular Disease $783,265

Dr. David Brown, M.d, M.D

Cardiovascular Disease — Payments: $256,750

Cardiovascular Disease $256,750

David Rawitscher, Md, MD

Cardiovascular Disease — Payments: $244,805

Cardiovascular Disease $244,805

Sahil Bakshi, Do, DO

Cardiovascular Disease — Payments: $193,440

Cardiovascular Disease $193,440

Dr. Vijay Ramanath, M.d, M.D

Cardiovascular Disease — Payments: $123,142

Cardiovascular Disease $123,142

Marc Shalek, Md, MD

Cardiovascular Disease — Payments: $106,177

Cardiovascular Disease $106,177